bibliographic entry 6352221 [be/6352221]
https://w3id.org/oc/corpus/be/6352221

is a

• bibliographic reference

content

• Glasspool, RM, Brown, R, Gore, ME, Rustin, GJ, McNeish, IA, Wilson, RH, Pledge, S, Paul, J, Mackean, M, Hall, GD, Gabra, H, Halford, SE, Walker, J, Appleton, K, Ullah, R, Kaye, S. A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer, British journal of cancer, 2014, 110, 1923, 1929, PMID: 24642620

references

• https://w3id.org/oc/corpus/br/3690977